These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 12844278

  • 1. [Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis findings in depressive disorder].
    Sarandöl A, Taneli B, Sivrioğlu Y.
    Turk Psikiyatri Derg; 2003; 14(2):116-24. PubMed ID: 12844278
    [Abstract] [Full Text] [Related]

  • 2. [The relation between results of thyrotropin-releasing hormone stimulation tests (TRH-ST), dexamethasone suppression test (DST) and urinary MHPG. SO4 excretion in depressive patients].
    Chen G.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):203-6, 251. PubMed ID: 1954790
    [Abstract] [Full Text] [Related]

  • 3. Hormonal differences between psychotic and non-psychotic melancholic depression.
    Contreras F, Menchon JM, Urretavizcaya M, Navarro MA, Vallejo J, Parker G.
    J Affect Disord; 2007 Jun; 100(1-3):65-73. PubMed ID: 17098292
    [Abstract] [Full Text] [Related]

  • 4. [Usefulness of neuroendocrine function tests in the differential diagnosis of depression].
    Cervera S.
    Rev Esp Fisiol; 1989 Jun; 45 Suppl():279-87. PubMed ID: 2518335
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine interrelationships in major depressive disorder.
    Targum SD, Sullivan AC, Byrnes SM.
    Am J Psychiatry; 1982 Mar; 139(3):282-6. PubMed ID: 6800269
    [Abstract] [Full Text] [Related]

  • 6. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB, Weller RA, Fristad MA, Preskorn SH, Teare M.
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [Abstract] [Full Text] [Related]

  • 7. The hypothalamic-pituitary-thyroid axis in depressive patients and healthy subjects in relation to the hypothalamic-pituitary-adrenal axis.
    Kjellman BF, Thorell LH, Orhagen T, d'Elia G, Kågedal B.
    Psychiatry Res; 1993 Apr; 47(1):7-21. PubMed ID: 8516419
    [Abstract] [Full Text] [Related]

  • 8. HPA- and HPT-axis alterations in chronic posttraumatic stress disorder.
    Olff M, Güzelcan Y, de Vries GJ, Assies J, Gersons BP.
    Psychoneuroendocrinology; 2006 Nov; 31(10):1220-30. PubMed ID: 17081699
    [Abstract] [Full Text] [Related]

  • 9. [The endocrine abnormalities of depressive patients].
    Yang Q.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Apr; 25(2):69-73, 125. PubMed ID: 1499410
    [Abstract] [Full Text] [Related]

  • 10. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E, Kartalci S, Tutus A, Turan T, Sofuoglu S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [Abstract] [Full Text] [Related]

  • 11. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates.
    Duval F, Mokrani MC, Monreal-Ortiz JA, Fattah S, Champeval C, Schulz P, Macher JP.
    Psychoneuroendocrinology; 2006 Aug; 31(7):876-88. PubMed ID: 16769179
    [Abstract] [Full Text] [Related]

  • 12. Hypothalamic-pituitary-end organ function in women with bipolar depression.
    Rasgon NL, Kenna HA, Wong ML, Whybrow PC, Bauer M.
    Psychoneuroendocrinology; 2007 Apr; 32(3):279-86. PubMed ID: 17317022
    [Abstract] [Full Text] [Related]

  • 13. The thyrotropin-releasing hormone test may predict recurrence of clinical depression within ten years after discharge.
    Tsuru J, Ishitobi Y, Ninomiya T, Kanehisa M, Imanaga J, Inoue A, Okamoto S, Maruyama Y, Higuma H, Tanaka Y, Hanada H, Isogawa K, Akiyoshi J.
    Neuro Endocrinol Lett; 2013 Apr; 34(5):409-17. PubMed ID: 23922049
    [Abstract] [Full Text] [Related]

  • 14. Neuroendocrine abnormalities in affective disorders.
    Extein I, Pottash AL, Gold MS.
    Encephale; 1982 Apr; 8(2):203-11. PubMed ID: 6809445
    [Abstract] [Full Text] [Related]

  • 15. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

  • 16. Depression and endocrine disorders: focus on the thyroid and adrenal system.
    Musselman DL, Nemeroff CB.
    Br J Psychiatry Suppl; 1996 Jun; (30):123-8. PubMed ID: 8864158
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal.
    Nemeroff CB.
    J Clin Psychiatry; 1989 May; 50 Suppl():13-20; discussion 21-2. PubMed ID: 2654128
    [Abstract] [Full Text] [Related]

  • 18. The dex/CRH test--is it better than the DST?
    Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH.
    Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
    [Abstract] [Full Text] [Related]

  • 19. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW.
    Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
    [Abstract] [Full Text] [Related]

  • 20. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE, Ettigi P.
    Clin Pharm; 1983 Jun; 2(6):538-45. PubMed ID: 6140096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.